Search

everythinglearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Co-trimoxazole may help treat autoimmune diseases.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Blocking interferon-gamma might help treat various autoimmune diseases.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.